Lonza bone marrow and cord blood mononuclear cells

Monday, 18 April, 2011 | Supplied by: Capsugel Australia Pty Ltd


Lonza’s bone marrow and cord blood mononuclear cells are prepared by centrifugation in a density cell separation medium (Ficoll-Paque, Amersham Pharmacia).

Isolating the mononuclear cells eliminates erythrocytes and granulocytes, producing a more stable cell product.

Mononuclear cells can be used directly in hematopoietic assays or as the starting material for isolating CD34+ progenitor cells.

Cells are available cryopreserved with varying numbers or cells per ampule, starting from >25 million cells.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

ProSci Incorporated apoptosis antibodies

ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death...

TdB Labs polysaccharides

TdB Labs' polysaccharide portfolio consists of both fluorescent and non-fluorescent...

Cayman Chemical Epigenetics Screening Library (96-Well)

The Cayman Chemical Epigenetics Screening Library (96-Well) is a compound library that is...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd